Desoxypeganine

US6558696B1 · kind B1 · utility

Assignees

• LTS Lohmann Therapie-Systeme AG · DE
• HF Arzneimittelforschung GmbH · DE

Inventors

• Thomas Hille · Neuwied, DE
• Lothar Deurer · Koblenz, DE

Key dates

• Filing date: Jul 25, 2001
• Grant date: May 6, 2003
• Expiry date: Jul 25, 2021

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P25/28
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to a transdermal therapeutic system (TTS) containing desoxypeganine (1,2,3,9-Tetrahydropyrrolo[2,1-b]quinazoline) as the active component, wherein the TSS includes a back layer impermeable to desoxypeganine and an adhesive reservoir layer that contains 10-80 weight percent polymeric material, 0.1-30 weight percent desoxypeganine and/or the pharmaceutically acceptable salts thereof and optionally a softening agent in proportions of 0.1-30 weight percent.